Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 8.14587054 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.14587054 |
3 | cellular response to interleukin-15 (GO:0071350) | 6.96083616 |
4 | regulation of memory T cell differentiation (GO:0043380) | 6.48166946 |
5 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 6.33501750 |
6 | response to interleukin-15 (GO:0070672) | 5.61771710 |
7 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 5.57108205 |
8 | L-phenylalanine catabolic process (GO:0006559) | 5.50803487 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.50803487 |
10 | regulation of T cell mediated cytotoxicity (GO:0001914) | 5.35622076 |
11 | L-phenylalanine metabolic process (GO:0006558) | 5.25327169 |
12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.25327169 |
13 | tolerance induction (GO:0002507) | 5.07287455 |
14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06764336 |
15 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.98156803 |
16 | positive regulation of defense response to virus by host (GO:0002230) | 4.95747856 |
17 | regulation of germinal center formation (GO:0002634) | 4.94397798 |
18 | sleep (GO:0030431) | 4.89505966 |
19 | aromatic amino acid family catabolic process (GO:0009074) | 4.79911807 |
20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.73553737 |
21 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.53474663 |
22 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.45218598 |
23 | bile acid biosynthetic process (GO:0006699) | 4.41312087 |
24 | urea cycle (GO:0000050) | 4.40129941 |
25 | urea metabolic process (GO:0019627) | 4.40129941 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.39926323 |
27 | negative regulation of fibrinolysis (GO:0051918) | 4.39874521 |
28 | kynurenine metabolic process (GO:0070189) | 4.38797123 |
29 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.36940112 |
30 | glyoxylate metabolic process (GO:0046487) | 4.34838244 |
31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.34242173 |
32 | cysteine metabolic process (GO:0006534) | 4.32960977 |
33 | lysine metabolic process (GO:0006553) | 4.29389210 |
34 | lysine catabolic process (GO:0006554) | 4.29389210 |
35 | regulation of activation of Janus kinase activity (GO:0010533) | 4.29157352 |
36 | sulfur amino acid catabolic process (GO:0000098) | 4.29132806 |
37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.29128123 |
38 | protein carboxylation (GO:0018214) | 4.29128123 |
39 | negative T cell selection (GO:0043383) | 4.26710509 |
40 | regulation of cell killing (GO:0031341) | 4.19714515 |
41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.18172125 |
42 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.16186895 |
43 | tryptophan catabolic process (GO:0006569) | 4.15824358 |
44 | indole-containing compound catabolic process (GO:0042436) | 4.15824358 |
45 | indolalkylamine catabolic process (GO:0046218) | 4.15824358 |
46 | complement activation, alternative pathway (GO:0006957) | 4.13925006 |
47 | positive regulation of osteoclast differentiation (GO:0045672) | 4.12689048 |
48 | negative thymic T cell selection (GO:0045060) | 4.11564885 |
49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.08307661 |
50 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.08097531 |
51 | high-density lipoprotein particle remodeling (GO:0034375) | 4.07631462 |
52 | regulation of T-helper 1 type immune response (GO:0002825) | 4.04419070 |
53 | regulation of fibrinolysis (GO:0051917) | 4.03488434 |
54 | regulation of protein activation cascade (GO:2000257) | 4.00480999 |
55 | nitrogen cycle metabolic process (GO:0071941) | 3.98474577 |
56 | regulation of cholesterol homeostasis (GO:2000188) | 3.96650714 |
57 | tryptophan metabolic process (GO:0006568) | 3.93912312 |
58 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.93579706 |
59 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.88133908 |
60 | dendritic cell chemotaxis (GO:0002407) | 3.84759682 |
61 | reverse cholesterol transport (GO:0043691) | 3.84195600 |
62 | positive regulation of T cell mediated immunity (GO:0002711) | 3.82106930 |
63 | regulation of complement activation (GO:0030449) | 3.77003270 |
64 | regulation of defense response to virus by host (GO:0050691) | 3.76467363 |
65 | glutamate metabolic process (GO:0006536) | 3.75647333 |
66 | bile acid metabolic process (GO:0008206) | 3.75055843 |
67 | regulation of triglyceride catabolic process (GO:0010896) | 3.74305698 |
68 | mast cell activation (GO:0045576) | 3.73623206 |
69 | lymph node development (GO:0048535) | 3.71781849 |
70 | response to gravity (GO:0009629) | 3.69710676 |
71 | homocysteine metabolic process (GO:0050667) | 3.68961958 |
72 | plasma lipoprotein particle clearance (GO:0034381) | 3.65892074 |
73 | positive regulation of cell killing (GO:0031343) | 3.64588609 |
74 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.64062362 |
75 | T-helper cell differentiation (GO:0042093) | 3.64062362 |
76 | cellular modified amino acid catabolic process (GO:0042219) | 3.63822764 |
77 | acylglycerol homeostasis (GO:0055090) | 3.63274363 |
78 | triglyceride homeostasis (GO:0070328) | 3.63274363 |
79 | histone H2A monoubiquitination (GO:0035518) | 3.63011932 |
80 | amino-acid betaine metabolic process (GO:0006577) | 3.62086194 |
81 | positive regulation of T cell cytokine production (GO:0002726) | 3.61660615 |
82 | regulation of T cell mediated immunity (GO:0002709) | 3.61615000 |
83 | cellular ketone body metabolic process (GO:0046950) | 3.61017183 |
84 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59610772 |
85 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.59463080 |
86 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.58390492 |
87 | tyrosine metabolic process (GO:0006570) | 3.54467125 |
88 | protein-lipid complex remodeling (GO:0034368) | 3.54450145 |
89 | macromolecular complex remodeling (GO:0034367) | 3.54450145 |
90 | plasma lipoprotein particle remodeling (GO:0034369) | 3.54450145 |
91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.49089515 |
92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47862600 |
93 | endoderm formation (GO:0001706) | 3.47449720 |
94 | negative regulation of cholesterol transport (GO:0032375) | 3.46628393 |
95 | negative regulation of sterol transport (GO:0032372) | 3.46628393 |
96 | interferon-gamma production (GO:0032609) | 3.42727320 |
97 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.42676621 |
98 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.42659584 |
99 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.41972175 |
100 | alpha-amino acid catabolic process (GO:1901606) | 3.41949910 |
101 | serine family amino acid catabolic process (GO:0009071) | 3.41099078 |
102 | regulation of cholesterol esterification (GO:0010872) | 3.40507926 |
103 | mitotic cell cycle arrest (GO:0071850) | 3.40169396 |
104 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.39710683 |
105 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.39710683 |
106 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38607408 |
107 | coenzyme catabolic process (GO:0009109) | 3.37480919 |
108 | response to muramyl dipeptide (GO:0032495) | 3.37127214 |
109 | aromatic amino acid family metabolic process (GO:0009072) | 3.37112170 |
110 | phospholipid efflux (GO:0033700) | 3.36083836 |
111 | rRNA catabolic process (GO:0016075) | 3.34881803 |
112 | aspartate family amino acid catabolic process (GO:0009068) | 3.33237103 |
113 | positive regulation of lipid catabolic process (GO:0050996) | 3.32519721 |
114 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31792280 |
115 | phospholipid homeostasis (GO:0055091) | 3.30038700 |
116 | ethanol oxidation (GO:0006069) | 3.29055224 |
117 | cellular defense response (GO:0006968) | 3.28821168 |
118 | short-chain fatty acid metabolic process (GO:0046459) | 3.28685571 |
119 | regulation of immunoglobulin secretion (GO:0051023) | 3.28660733 |
120 | mast cell activation involved in immune response (GO:0002279) | 3.28323417 |
121 | mast cell degranulation (GO:0043303) | 3.28323417 |
122 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28173238 |
123 | cholesterol efflux (GO:0033344) | 3.27222364 |
124 | T cell differentiation involved in immune response (GO:0002292) | 3.24733747 |
125 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.24733747 |
126 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.24733747 |
127 | cellular amino acid catabolic process (GO:0009063) | 3.24483758 |
128 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.23399164 |
129 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22632735 |
130 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.19387636 |
131 | ketone body metabolic process (GO:1902224) | 3.18614529 |
132 | positive regulation of cell fate commitment (GO:0010455) | 3.16416171 |
133 | acetyl-CoA metabolic process (GO:0006084) | 3.15355475 |
134 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.15275168 |
135 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.15275168 |
136 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.14480910 |
137 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.14181076 |
138 | negative regulation of bone resorption (GO:0045779) | 3.13159598 |
139 | plasma lipoprotein particle assembly (GO:0034377) | 3.12258987 |
140 | fibrinolysis (GO:0042730) | 3.12184495 |
141 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11603611 |
142 | cellular glucuronidation (GO:0052695) | 3.10852006 |
143 | fatty acid beta-oxidation (GO:0006635) | 3.10649967 |
144 | cytidine metabolic process (GO:0046087) | 3.10004836 |
145 | cytidine catabolic process (GO:0006216) | 3.10004836 |
146 | cytidine deamination (GO:0009972) | 3.10004836 |
147 | negative regulation of lipid storage (GO:0010888) | 3.09424975 |
148 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.08196767 |
149 | bile acid and bile salt transport (GO:0015721) | 3.08185012 |
150 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.07615749 |
151 | protein-lipid complex assembly (GO:0065005) | 3.07467467 |
152 | fatty acid oxidation (GO:0019395) | 3.07135896 |
153 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.06397820 |
154 | positive regulation of interleukin-17 production (GO:0032740) | 3.05087145 |
155 | regulation of natural killer cell activation (GO:0032814) | 3.04976899 |
156 | benzene-containing compound metabolic process (GO:0042537) | 3.04964061 |
157 | DNA deamination (GO:0045006) | 3.03204481 |
158 | lipid oxidation (GO:0034440) | 3.02664202 |
159 | negative regulation of lipase activity (GO:0060192) | 3.01614430 |
160 | dendritic cell migration (GO:0036336) | 2.99417728 |
161 | germ cell migration (GO:0008354) | 2.99034323 |
162 | drug catabolic process (GO:0042737) | 2.98760160 |
163 | monocarboxylic acid catabolic process (GO:0072329) | 2.98643424 |
164 | regulation of regulatory T cell differentiation (GO:0045589) | 2.98415268 |
165 | drug transmembrane transport (GO:0006855) | 2.98207268 |
166 | regulation of plasminogen activation (GO:0010755) | 2.97485803 |
167 | positive regulation of fatty acid oxidation (GO:0046321) | 2.97293764 |
168 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96861559 |
169 | fatty acid catabolic process (GO:0009062) | 2.96444752 |
170 | cholesterol homeostasis (GO:0042632) | 2.95792187 |
171 | valine metabolic process (GO:0006573) | 2.95556177 |
172 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.95470866 |
173 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.95470866 |
174 | isotype switching (GO:0045190) | 2.95470866 |
175 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.95115662 |
176 | sterol homeostasis (GO:0055092) | 2.94058758 |
177 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93423237 |
178 | positive thymic T cell selection (GO:0045059) | 2.92941247 |
179 | negative regulation of innate immune response (GO:0045824) | 2.91347333 |
180 | carboxylic acid catabolic process (GO:0046395) | 2.91253349 |
181 | organic acid catabolic process (GO:0016054) | 2.91253349 |
182 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.90124236 |
183 | positive regulation of prostaglandin secretion (GO:0032308) | 2.89051505 |
184 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.89041490 |
185 | lipoprotein metabolic process (GO:0042157) | 2.87356448 |
186 | negative regulation of meiotic cell cycle (GO:0051447) | 2.87230209 |
187 | indolalkylamine metabolic process (GO:0006586) | 2.86855602 |
188 | carnitine metabolic process (GO:0009437) | 2.86336751 |
189 | complement activation, classical pathway (GO:0006958) | 2.86153215 |
190 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.85300212 |
191 | alpha-beta T cell differentiation (GO:0046632) | 2.84884158 |
192 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.84615756 |
193 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.84426486 |
194 | complement activation (GO:0006956) | 2.81928827 |
195 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81813548 |
196 | epoxygenase P450 pathway (GO:0019373) | 2.81761481 |
197 | regulation of cholesterol metabolic process (GO:0090181) | 2.81759767 |
198 | positive regulation of cholesterol efflux (GO:0010875) | 2.81713225 |
199 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.81632440 |
200 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.80496516 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.64371920 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.11993569 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.59956738 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.47464706 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.84442811 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.71777227 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.56119329 |
8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.97365037 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.94610003 |
10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.39970213 |
11 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.39398763 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.10970029 |
13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.75590778 |
14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59564820 |
15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29391209 |
16 | * MYB_26560356_Chip-Seq_TH2_Human | 2.28943209 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27169065 |
18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23649802 |
19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.20432347 |
20 | * GATA3_26560356_Chip-Seq_TH2_Human | 2.14538118 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09007776 |
22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.08166219 |
23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06525626 |
24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.04505908 |
25 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.99374533 |
26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96172043 |
27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95051272 |
28 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.89021070 |
29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83545857 |
30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78868533 |
31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77007884 |
32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70988643 |
33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66670481 |
34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61239566 |
35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58711938 |
36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.56668297 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54078182 |
38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50045843 |
39 | MYB_26560356_Chip-Seq_TH1_Human | 1.49862963 |
40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49232505 |
41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48771129 |
42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47357736 |
43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44601895 |
44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44249756 |
45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44174215 |
46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43416957 |
47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40656685 |
48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37800935 |
49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36229284 |
50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33924423 |
51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32296477 |
52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28876802 |
53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28441170 |
54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27661113 |
55 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22585581 |
56 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22487037 |
57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21615201 |
58 | MAF_26560356_Chip-Seq_TH1_Human | 1.20792335 |
59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20181557 |
60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19202421 |
61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18241861 |
62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18241861 |
63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17181613 |
64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14717643 |
65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13438483 |
66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12957215 |
67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12944834 |
68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12708183 |
69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10595390 |
70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09508659 |
71 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08873118 |
72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08190982 |
73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07976579 |
74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07352487 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06631377 |
76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06476325 |
77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06257312 |
78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05669136 |
79 | P300_27268052_Chip-Seq_Bcells_Human | 1.05319208 |
80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05121839 |
81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04954524 |
82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04089150 |
83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03403490 |
84 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02969837 |
85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02616527 |
86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01994353 |
87 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99797250 |
88 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99601786 |
89 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99478759 |
90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99478759 |
91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98630014 |
92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97214152 |
93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96226859 |
94 | MAF_26560356_Chip-Seq_TH2_Human | 0.95549675 |
95 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95262764 |
96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.94916203 |
97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94767857 |
98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94206018 |
99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.94080173 |
100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93328917 |
101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92190449 |
102 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.91048086 |
103 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90955553 |
104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90858413 |
105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90768699 |
106 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90412169 |
107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90308849 |
108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89238878 |
109 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.89079281 |
110 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.88610242 |
111 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88369291 |
112 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88360755 |
113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.88162570 |
114 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87584146 |
115 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.87315632 |
116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87176324 |
117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86836328 |
118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86747670 |
119 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.86424932 |
120 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.85799790 |
121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85695048 |
122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84508725 |
123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84416833 |
124 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84007228 |
125 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.83982258 |
126 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.83942372 |
127 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.83621554 |
128 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83573518 |
129 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83393252 |
130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83382942 |
131 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83235972 |
132 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.81998973 |
133 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.81785517 |
134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81666166 |
135 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81568845 |
136 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81017217 |
137 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.80613855 |
138 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.80613855 |
139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80397534 |
140 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80292694 |
141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80060485 |
142 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80004092 |
143 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79891996 |
144 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.79639111 |
145 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.78850475 |
146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77417705 |
147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76609638 |
148 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.76130344 |
149 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.76050501 |
150 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75963157 |
151 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75683971 |
152 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75438109 |
153 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75365907 |
154 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.74414912 |
155 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.73668259 |
156 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73573894 |
157 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73474059 |
158 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.73416980 |
159 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73252473 |
160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72950540 |
161 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.72773598 |
162 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72500285 |
163 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72494514 |
164 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72120180 |
165 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.71564813 |
166 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71127154 |
167 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71033804 |
168 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.69443885 |
169 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.69347025 |
170 | RXR_22108803_ChIP-Seq_LS180_Human | 0.68654554 |
171 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.68530411 |
172 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68488214 |
173 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.68188562 |
174 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.67089393 |
175 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67009567 |
176 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66790460 |
177 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.66547987 |
178 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.66461156 |
179 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.66370907 |
180 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.66315626 |
181 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66034069 |
182 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.65037630 |
183 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.64156177 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.55349366 |
2 | MP0005360_urolithiasis | 6.04654210 |
3 | MP0005365_abnormal_bile_salt | 5.14371905 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.83715838 |
5 | MP0003724_increased_susceptibility_to | 4.62542899 |
6 | MP0005671_abnormal_response_to | 4.35669299 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.91555820 |
8 | MP0003252_abnormal_bile_duct | 3.43436940 |
9 | MP0003436_decreased_susceptibility_to | 3.28657923 |
10 | MP0003763_abnormal_thymus_physiology | 3.18903180 |
11 | MP0010329_abnormal_lipoprotein_level | 3.16681570 |
12 | MP0005000_abnormal_immune_tolerance | 3.01966168 |
13 | MP0000685_abnormal_immune_system | 3.00955100 |
14 | MP0009840_abnormal_foam_cell | 2.89138189 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.83293251 |
16 | MP0002876_abnormal_thyroid_physiology | 2.63335772 |
17 | MP0000465_gastrointestinal_hemorrhage | 2.61918804 |
18 | MP0003195_calcinosis | 2.60468245 |
19 | MP0005083_abnormal_biliary_tract | 2.60301339 |
20 | MP0001835_abnormal_antigen_presentation | 2.48580492 |
21 | MP0003806_abnormal_nucleotide_metabolis | 2.44587363 |
22 | MP0004147_increased_porphyrin_level | 2.42178809 |
23 | MP0004885_abnormal_endolymph | 2.37218287 |
24 | MP0005332_abnormal_amino_acid | 2.35253292 |
25 | MP0001800_abnormal_humoral_immune | 2.34389935 |
26 | MP0001533_abnormal_skeleton_physiology | 2.33931394 |
27 | MP0004947_skin_inflammation | 2.31594941 |
28 | MP0002723_abnormal_immune_serum | 2.30407010 |
29 | MP0003705_abnormal_hypodermis_morpholog | 2.27329083 |
30 | MP0009785_altered_susceptibility_to | 2.27120378 |
31 | MP0001666_abnormal_nutrient_absorption | 2.24318055 |
32 | MP0002148_abnormal_hypersensitivity_rea | 2.20321285 |
33 | MP0003866_abnormal_defecation | 2.02817919 |
34 | MP0006072_abnormal_retinal_apoptosis | 2.01322616 |
35 | MP0005075_abnormal_melanosome_morpholog | 1.98955294 |
36 | MP0002118_abnormal_lipid_homeostasis | 1.98804990 |
37 | MP0001819_abnormal_immune_cell | 1.98756192 |
38 | MP0002452_abnormal_antigen_presenting | 1.94947360 |
39 | MP0003878_abnormal_ear_physiology | 1.93568318 |
40 | MP0005377_hearing/vestibular/ear_phenot | 1.93568318 |
41 | MP0002420_abnormal_adaptive_immunity | 1.92392710 |
42 | MP0000609_abnormal_liver_physiology | 1.92164724 |
43 | MP0001501_abnormal_sleep_pattern | 1.91546009 |
44 | MP0002009_preneoplasia | 1.84705106 |
45 | MP0002933_joint_inflammation | 1.84026877 |
46 | MP0001790_abnormal_immune_system | 1.75051290 |
47 | MP0005387_immune_system_phenotype | 1.75051290 |
48 | MP0003329_amyloid_beta_deposits | 1.72884237 |
49 | MP0005025_abnormal_response_to | 1.72023788 |
50 | MP0000604_amyloidosis | 1.69627795 |
51 | MP0002138_abnormal_hepatobiliary_system | 1.68852749 |
52 | MP0002419_abnormal_innate_immunity | 1.67804569 |
53 | MP0004130_abnormal_muscle_cell | 1.59812605 |
54 | MP0002405_respiratory_system_inflammati | 1.59393700 |
55 | MP0003868_abnormal_feces_composition | 1.58520844 |
56 | MP0005319_abnormal_enzyme/_coenzyme | 1.55194965 |
57 | MP0003300_gastrointestinal_ulcer | 1.52642918 |
58 | MP0004019_abnormal_vitamin_homeostasis | 1.48328685 |
59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47542227 |
60 | MP0010155_abnormal_intestine_physiology | 1.47332977 |
61 | MP0002166_altered_tumor_susceptibility | 1.47163534 |
62 | MP0003879_abnormal_hair_cell | 1.45589540 |
63 | MP0001845_abnormal_inflammatory_respons | 1.44767871 |
64 | MP0002837_dystrophic_cardiac_calcinosis | 1.43692197 |
65 | MP0002398_abnormal_bone_marrow | 1.42171133 |
66 | MP0000689_abnormal_spleen_morphology | 1.38466917 |
67 | MP0000716_abnormal_immune_system | 1.38439205 |
68 | MP0003828_pulmonary_edema | 1.36710116 |
69 | MP0001348_abnormal_lacrimal_gland | 1.36441928 |
70 | MP0002722_abnormal_immune_system | 1.33589103 |
71 | MP0001919_abnormal_reproductive_system | 1.31134809 |
72 | MP0009643_abnormal_urine_homeostasis | 1.30889735 |
73 | MP0008438_abnormal_cutaneous_collagen | 1.29698751 |
74 | MP0002102_abnormal_ear_morphology | 1.28865312 |
75 | MP0000703_abnormal_thymus_morphology | 1.28498621 |
76 | MP0003690_abnormal_glial_cell | 1.26975476 |
77 | MP0009780_abnormal_chondrocyte_physiolo | 1.20767860 |
78 | MP0010234_abnormal_vibrissa_follicle | 1.20766603 |
79 | MP0002998_abnormal_bone_remodeling | 1.17630786 |
80 | MP0005390_skeleton_phenotype | 1.17567412 |
81 | MP0003656_abnormal_erythrocyte_physiolo | 1.14551943 |
82 | MP0005058_abnormal_lysosome_morphology | 1.11499011 |
83 | MP0003638_abnormal_response/metabolism_ | 1.07286294 |
84 | MP0009384_cardiac_valve_regurgitation | 1.07031677 |
85 | MP0001986_abnormal_taste_sensitivity | 1.06481043 |
86 | MP0004145_abnormal_muscle_electrophysio | 1.04950864 |
87 | MP0005666_abnormal_adipose_tissue | 1.03761141 |
88 | MP0003303_peritoneal_inflammation | 1.03264236 |
89 | MP0003075_altered_response_to | 1.02654865 |
90 | MP0002006_tumorigenesis | 1.02605236 |
91 | MP0002429_abnormal_blood_cell | 1.01157592 |
92 | MP0004381_abnormal_hair_follicle | 0.99993062 |
93 | MP0008877_abnormal_DNA_methylation | 0.99813992 |
94 | MP0005167_abnormal_blood-brain_barrier | 0.99746828 |
95 | MP0002078_abnormal_glucose_homeostasis | 0.98859275 |
96 | MP0005670_abnormal_white_adipose | 0.98729093 |
97 | MP0008872_abnormal_physiological_respon | 0.98479927 |
98 | MP0008775_abnormal_heart_ventricle | 0.97478202 |
99 | MP0002971_abnormal_brown_adipose | 0.97332454 |
100 | MP0005174_abnormal_tail_pigmentation | 0.96582780 |
101 | MP0000598_abnormal_liver_morphology | 0.95945126 |
102 | MP0002909_abnormal_adrenal_gland | 0.95684701 |
103 | MP0005310_abnormal_salivary_gland | 0.95068228 |
104 | MP0010368_abnormal_lymphatic_system | 0.94867559 |
105 | MP0005646_abnormal_pituitary_gland | 0.94453084 |
106 | MP0005647_abnormal_sex_gland | 0.92671115 |
107 | MP0005253_abnormal_eye_physiology | 0.89118798 |
108 | MP0004185_abnormal_adipocyte_glucose | 0.88633244 |
109 | MP0005451_abnormal_body_composition | 0.87345545 |
110 | MP0003646_muscle_fatigue | 0.86784596 |
111 | MP0009333_abnormal_splenocyte_physiolog | 0.86041562 |
112 | MP0005464_abnormal_platelet_physiology | 0.84919129 |
113 | MP0003011_delayed_dark_adaptation | 0.84895799 |
114 | MP0005535_abnormal_body_temperature | 0.84824808 |
115 | MP0008961_abnormal_basal_metabolism | 0.84374583 |
116 | MP0005636_abnormal_mineral_homeostasis | 0.83558904 |
117 | MP0004043_abnormal_pH_regulation | 0.82905898 |
118 | MP0005551_abnormal_eye_electrophysiolog | 0.82250224 |
119 | MP0009764_decreased_sensitivity_to | 0.81579232 |
120 | MP0005334_abnormal_fat_pad | 0.80372140 |
121 | MP0001764_abnormal_homeostasis | 0.80190014 |
122 | MP0001853_heart_inflammation | 0.79187597 |
123 | MP0003795_abnormal_bone_structure | 0.79113109 |
124 | MP0001851_eye_inflammation | 0.78311849 |
125 | MP0009642_abnormal_blood_homeostasis | 0.76747017 |
126 | MP0005408_hypopigmentation | 0.75827399 |
127 | MP0001756_abnormal_urination | 0.75535813 |
128 | MP0001542_abnormal_bone_strength | 0.74505073 |
129 | MP0002254_reproductive_system_inflammat | 0.74108909 |
130 | MP0009763_increased_sensitivity_to | 0.73846395 |
131 | MP0005248_abnormal_Harderian_gland | 0.73360655 |
132 | MP0002168_other_aberrant_phenotype | 0.73133268 |
133 | MP0000383_abnormal_hair_follicle | 0.73041713 |
134 | MP0005375_adipose_tissue_phenotype | 0.72986106 |
135 | MP0001243_abnormal_dermal_layer | 0.72253486 |
136 | MP0001502_abnormal_circadian_rhythm | 0.71253427 |
137 | MP0005220_abnormal_exocrine_pancreas | 0.70878438 |
138 | MP0005389_reproductive_system_phenotype | 0.70673452 |
139 | MP0001765_abnormal_ion_homeostasis | 0.69996934 |
140 | MP0002090_abnormal_vision | 0.69924196 |
141 | MP0004858_abnormal_nervous_system | 0.68392816 |
142 | MP0005166_decreased_susceptibility_to | 0.67729140 |
143 | MP0008469_abnormal_protein_level | 0.67365216 |
144 | MP0006082_CNS_inflammation | 0.66193678 |
145 | MP0000747_muscle_weakness | 0.64976603 |
146 | MP0000013_abnormal_adipose_tissue | 0.64287689 |
147 | MP0001873_stomach_inflammation | 0.64096472 |
148 | MP0009053_abnormal_anal_canal | 0.62253710 |
149 | MP0005448_abnormal_energy_balance | 0.61774916 |
150 | MP0000639_abnormal_adrenal_gland | 0.60910820 |
151 | MP0003633_abnormal_nervous_system | 0.60555409 |
152 | MP0002295_abnormal_pulmonary_circulatio | 0.60361148 |
153 | MP0003045_fibrosis | 0.60275220 |
154 | MP0004087_abnormal_muscle_fiber | 0.59352426 |
155 | MP0002877_abnormal_melanocyte_morpholog | 0.59089993 |
156 | MP0002896_abnormal_bone_mineralization | 0.58883227 |
157 | MP0000751_myopathy | 0.57097536 |
158 | MP0003172_abnormal_lysosome_physiology | 0.56551263 |
159 | MP0008874_decreased_physiological_sensi | 0.56488447 |
160 | MP0005275_abnormal_skin_tensile | 0.55858181 |
161 | MP0005330_cardiomyopathy | 0.54053551 |
162 | MP0001958_emphysema | 0.53915664 |
163 | MP0002269_muscular_atrophy | 0.53291068 |
164 | MP0002136_abnormal_kidney_physiology | 0.53102773 |
165 | MP0000230_abnormal_systemic_arterial | 0.51524607 |
166 | MP0001944_abnormal_pancreas_morphology | 0.50946526 |
167 | MP0003953_abnormal_hormone_level | 0.49617172 |
168 | MP0002928_abnormal_bile_duct | 0.49559217 |
169 | MP0004036_abnormal_muscle_relaxation | 0.48612942 |
170 | MP0000249_abnormal_blood_vessel | 0.48162693 |
171 | MP0003186_abnormal_redox_activity | 0.47947925 |
172 | MP0001661_extended_life_span | 0.46404540 |
173 | MP0000003_abnormal_adipose_tissue | 0.46205881 |
174 | MP0003566_abnormal_cell_adhesion | 0.45481631 |
175 | MP0000920_abnormal_myelination | 0.44399721 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IgG deficiency (HP:0004315) | 7.38402536 |
2 | Deep venous thrombosis (HP:0002625) | 6.21406543 |
3 | Optic neuritis (HP:0100653) | 5.41616018 |
4 | Retrobulbar optic neuritis (HP:0100654) | 5.41616018 |
5 | Xanthomatosis (HP:0000991) | 5.23730022 |
6 | Severe combined immunodeficiency (HP:0004430) | 5.19247797 |
7 | Intrahepatic cholestasis (HP:0001406) | 5.17185569 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.13005325 |
9 | Myositis (HP:0100614) | 5.01072194 |
10 | T lymphocytopenia (HP:0005403) | 4.97679905 |
11 | Orchitis (HP:0100796) | 4.85722460 |
12 | Abnormality of T cell number (HP:0011839) | 4.73106034 |
13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.65021397 |
14 | Abnormality of eosinophils (HP:0001879) | 4.62553018 |
15 | Complement deficiency (HP:0004431) | 4.57291372 |
16 | Prostate neoplasm (HP:0100787) | 4.26941895 |
17 | Conical tooth (HP:0000698) | 4.24891184 |
18 | Hyperlipoproteinemia (HP:0010980) | 4.20452108 |
19 | Stomach cancer (HP:0012126) | 4.11946099 |
20 | Hypobetalipoproteinemia (HP:0003563) | 4.04977124 |
21 | Prolonged partial thromboplastin time (HP:0003645) | 4.04948243 |
22 | Combined immunodeficiency (HP:0005387) | 3.99815012 |
23 | Ketosis (HP:0001946) | 3.94268170 |
24 | Thyroiditis (HP:0100646) | 3.93325915 |
25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.82130174 |
26 | Renal cortical cysts (HP:0000803) | 3.80548217 |
27 | Persistence of primary teeth (HP:0006335) | 3.78233101 |
28 | Abnormality of T cells (HP:0002843) | 3.73790491 |
29 | Hypoglycemic coma (HP:0001325) | 3.68362914 |
30 | Hypoalphalipoproteinemia (HP:0003233) | 3.65991769 |
31 | Hyperammonemia (HP:0001987) | 3.60484450 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.60414485 |
33 | Keratoconjunctivitis (HP:0001096) | 3.59844032 |
34 | Hypolipoproteinemia (HP:0010981) | 3.57141648 |
35 | Epidermoid cyst (HP:0200040) | 3.52664188 |
36 | Ketoacidosis (HP:0001993) | 3.44771680 |
37 | Stomatitis (HP:0010280) | 3.44122241 |
38 | Keratoconjunctivitis sicca (HP:0001097) | 3.33496509 |
39 | Abnormality of complement system (HP:0005339) | 3.33346154 |
40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.26497106 |
41 | Joint hemorrhage (HP:0005261) | 3.18448416 |
42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.15875537 |
43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.09261824 |
44 | Abnormality of glycine metabolism (HP:0010895) | 3.09261824 |
45 | Pulmonary infiltrates (HP:0002113) | 3.08968558 |
46 | Myocardial infarction (HP:0001658) | 3.07221836 |
47 | Hyperglycinemia (HP:0002154) | 3.02941005 |
48 | Abnormality of T cell physiology (HP:0011840) | 3.00114136 |
49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.97737169 |
50 | Hyperglycinuria (HP:0003108) | 2.97177351 |
51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95361327 |
52 | Eosinophilia (HP:0001880) | 2.89892315 |
53 | Abnormality of the renal cortex (HP:0011035) | 2.88601709 |
54 | Skin nodule (HP:0200036) | 2.85198787 |
55 | Brittle hair (HP:0002299) | 2.83635732 |
56 | Fat malabsorption (HP:0002630) | 2.83597862 |
57 | Eczematoid dermatitis (HP:0000976) | 2.80441032 |
58 | Leukocytosis (HP:0001974) | 2.76145994 |
59 | Pustule (HP:0200039) | 2.75880536 |
60 | Pulmonary fibrosis (HP:0002206) | 2.75112521 |
61 | Hypercholesterolemia (HP:0003124) | 2.73152761 |
62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.72348877 |
63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.71124090 |
64 | Type II lissencephaly (HP:0007260) | 2.69339974 |
65 | Abnormality of the prostate (HP:0008775) | 2.67873763 |
66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.64799032 |
67 | Hepatocellular carcinoma (HP:0001402) | 2.62381322 |
68 | Anhidrosis (HP:0000970) | 2.61225517 |
69 | Joint swelling (HP:0001386) | 2.61121445 |
70 | Hypoglycemic seizures (HP:0002173) | 2.59019564 |
71 | Clumsiness (HP:0002312) | 2.58363791 |
72 | Granulocytopenia (HP:0001913) | 2.53145011 |
73 | Gout (HP:0001997) | 2.52828546 |
74 | Mitral stenosis (HP:0001718) | 2.52046340 |
75 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51912131 |
76 | Systemic lupus erythematosus (HP:0002725) | 2.46800600 |
77 | Abnormality of methionine metabolism (HP:0010901) | 2.45258555 |
78 | Recurrent bronchitis (HP:0002837) | 2.44364735 |
79 | Abnormality of purine metabolism (HP:0004352) | 2.41814157 |
80 | Encephalitis (HP:0002383) | 2.37851442 |
81 | Arterial thrombosis (HP:0004420) | 2.37677389 |
82 | Hyperbilirubinemia (HP:0002904) | 2.34824915 |
83 | Amyloidosis (HP:0011034) | 2.33960079 |
84 | Congenital stationary night blindness (HP:0007642) | 2.30225037 |
85 | Vasculitis (HP:0002633) | 2.29161266 |
86 | Facial diplegia (HP:0001349) | 2.25553819 |
87 | Asplenia (HP:0001746) | 2.25086014 |
88 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24904623 |
89 | Hemoptysis (HP:0002105) | 2.24140906 |
90 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.23280086 |
91 | Keratitis (HP:0000491) | 2.22384326 |
92 | Cholelithiasis (HP:0001081) | 2.21227320 |
93 | Delayed CNS myelination (HP:0002188) | 2.20925320 |
94 | Abnormal gallbladder morphology (HP:0012437) | 2.20774175 |
95 | Abnormality of the Achilles tendon (HP:0005109) | 2.20010216 |
96 | Abnormality of proline metabolism (HP:0010907) | 2.16515896 |
97 | Hydroxyprolinuria (HP:0003080) | 2.16515896 |
98 | Sensorimotor neuropathy (HP:0007141) | 2.15203748 |
99 | Spastic diplegia (HP:0001264) | 2.14758013 |
100 | Growth hormone excess (HP:0000845) | 2.14707842 |
101 | Gangrene (HP:0100758) | 2.14625447 |
102 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13353011 |
103 | Metabolic alkalosis (HP:0200114) | 2.12533385 |
104 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.11888899 |
105 | Spontaneous abortion (HP:0005268) | 2.11255775 |
106 | Abnormal gallbladder physiology (HP:0012438) | 2.10908160 |
107 | Cholecystitis (HP:0001082) | 2.10908160 |
108 | Glomerulonephritis (HP:0000099) | 2.10481298 |
109 | Vascular calcification (HP:0004934) | 2.10165696 |
110 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.10002836 |
111 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.09522906 |
112 | Esophageal varix (HP:0002040) | 2.08906597 |
113 | Hyperglycemia (HP:0003074) | 2.07200727 |
114 | Adactyly (HP:0009776) | 2.06670064 |
115 | Late onset (HP:0003584) | 2.06125936 |
116 | Neonatal onset (HP:0003623) | 2.05441905 |
117 | Glomerulopathy (HP:0100820) | 2.04891725 |
118 | Cardiovascular calcification (HP:0011915) | 2.04831774 |
119 | Vertigo (HP:0002321) | 2.02886172 |
120 | Abnormality of dental color (HP:0011073) | 2.00332855 |
121 | Myoglobinuria (HP:0002913) | 1.99743283 |
122 | Acanthocytosis (HP:0001927) | 1.98839578 |
123 | Esophageal neoplasm (HP:0100751) | 1.98327896 |
124 | Neoplasm of head and neck (HP:0012288) | 1.98327896 |
125 | Metabolic acidosis (HP:0001942) | 1.98280530 |
126 | Back pain (HP:0003418) | 1.98137075 |
127 | Premature loss of primary teeth (HP:0006323) | 1.97743368 |
128 | Hypoplasia of the uterus (HP:0000013) | 1.95208301 |
129 | Anorexia (HP:0002039) | 1.94698588 |
130 | Chronic diarrhea (HP:0002028) | 1.93593542 |
131 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93293173 |
132 | Abnormality of the renal collecting system (HP:0004742) | 1.92081957 |
133 | Hypoplasia of the pons (HP:0012110) | 1.91411768 |
134 | Cerebral inclusion bodies (HP:0100314) | 1.90320677 |
135 | Recurrent fungal infections (HP:0002841) | 1.89336129 |
136 | Duplicated collecting system (HP:0000081) | 1.88759190 |
137 | Turricephaly (HP:0000262) | 1.88192683 |
138 | Pulmonary embolism (HP:0002204) | 1.87947601 |
139 | Steatorrhea (HP:0002570) | 1.87889775 |
140 | Lymphangioma (HP:0100764) | 1.87330847 |
141 | Neurofibrillary tangles (HP:0002185) | 1.86865295 |
142 | Abnormality of serum amino acid levels (HP:0003112) | 1.86326493 |
143 | Abnormality of B cell number (HP:0010975) | 1.85796613 |
144 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85761205 |
145 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85761205 |
146 | Peritonitis (HP:0002586) | 1.85265984 |
147 | Abnormality of the endocardium (HP:0004306) | 1.84938402 |
148 | Nephritis (HP:0000123) | 1.83892936 |
149 | Increased IgM level (HP:0003496) | 1.83574160 |
150 | Global brain atrophy (HP:0002283) | 1.82961854 |
151 | Abnormality of the pleura (HP:0002103) | 1.81731562 |
152 | Enlarged kidneys (HP:0000105) | 1.79494415 |
153 | Dicarboxylic aciduria (HP:0003215) | 1.78938854 |
154 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78938854 |
155 | Bundle branch block (HP:0011710) | 1.78886159 |
156 | Decreased subcutaneous fat (HP:0001002) | 1.78810101 |
157 | Short tibia (HP:0005736) | 1.78409826 |
158 | Polycythemia (HP:0001901) | 1.78234113 |
159 | Polyneuropathy (HP:0001271) | 1.77786953 |
160 | Gastrointestinal stroma tumor (HP:0100723) | 1.76710332 |
161 | Abnormal cartilage morphology (HP:0002763) | 1.76651742 |
162 | Hypotrichosis (HP:0001006) | 1.75822482 |
163 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75187881 |
164 | Abnormality of the pons (HP:0007361) | 1.74815764 |
165 | Hemorrhage of the eye (HP:0011885) | 1.74683266 |
166 | Abnormality of the pericardium (HP:0001697) | 1.74077280 |
167 | Tongue fasciculations (HP:0001308) | 1.72384382 |
168 | Stroke (HP:0001297) | 1.72215266 |
169 | Abnormality of the gallbladder (HP:0005264) | 1.72142587 |
170 | Malnutrition (HP:0004395) | 1.71909905 |
171 | Increased density of long bones (HP:0006392) | 1.71605621 |
172 | Irritability (HP:0000737) | 1.71393570 |
173 | Menorrhagia (HP:0000132) | 1.70626535 |
174 | Protuberant abdomen (HP:0001538) | 1.68537552 |
175 | Arthralgia (HP:0002829) | 1.68003241 |
176 | IgA deficiency (HP:0002720) | 1.67884364 |
177 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.66735248 |
178 | Alkalosis (HP:0001948) | 1.66244784 |
179 | Status epilepticus (HP:0002133) | 1.65762456 |
180 | Hypokalemic alkalosis (HP:0001949) | 1.65621071 |
181 | Achilles tendon contracture (HP:0001771) | 1.65582712 |
182 | Gastrointestinal infarctions (HP:0005244) | 1.64996886 |
183 | B lymphocytopenia (HP:0010976) | 1.63869746 |
184 | Progressive microcephaly (HP:0000253) | 1.62633927 |
185 | Increased purine levels (HP:0004368) | 1.62364367 |
186 | Hyperuricemia (HP:0002149) | 1.62364367 |
187 | Exercise-induced myalgia (HP:0003738) | 1.61674253 |
188 | Mediastinal lymphadenopathy (HP:0100721) | 1.61149263 |
189 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.61074823 |
190 | Pancreatitis (HP:0001733) | 1.60868058 |
191 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.60652381 |
192 | Reticulocytosis (HP:0001923) | 1.60328484 |
193 | Mucopolysacchariduria (HP:0008155) | 1.60189224 |
194 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.60189224 |
195 | Gingival bleeding (HP:0000225) | 1.59360239 |
196 | Nephronophthisis (HP:0000090) | 1.59183384 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 6.24469782 |
2 | MAP2K2 | 4.40969621 |
3 | TRIB3 | 4.16794147 |
4 | MAP3K14 | 4.04709470 |
5 | TLK1 | 3.30563349 |
6 | PKN2 | 3.13402683 |
7 | SIK1 | 3.09501634 |
8 | ERN1 | 3.02444445 |
9 | BCKDK | 2.73785663 |
10 | FGFR4 | 2.47621842 |
11 | RIPK1 | 2.22176752 |
12 | IKBKB | 2.17180119 |
13 | INSRR | 2.16176631 |
14 | TESK2 | 2.10374334 |
15 | PTK6 | 2.07836555 |
16 | TAOK3 | 2.03559249 |
17 | ZAK | 2.00105923 |
18 | IKBKE | 1.91284024 |
19 | TTN | 1.90097191 |
20 | EPHB1 | 1.88431877 |
21 | MAP4K1 | 1.76847232 |
22 | FES | 1.65231332 |
23 | ADRBK2 | 1.63768711 |
24 | LATS1 | 1.56020385 |
25 | FRK | 1.51941283 |
26 | PDGFRA | 1.49005826 |
27 | KSR2 | 1.40569347 |
28 | MUSK | 1.40103743 |
29 | MAP2K4 | 1.39253795 |
30 | KIT | 1.37149557 |
31 | KDR | 1.35944001 |
32 | RET | 1.34198548 |
33 | FGFR2 | 1.33325430 |
34 | EPHA3 | 1.31603524 |
35 | SIK2 | 1.29596911 |
36 | DAPK2 | 1.29136238 |
37 | PRKD3 | 1.29136091 |
38 | MATK | 1.27274978 |
39 | MAP3K2 | 1.27253411 |
40 | GRK7 | 1.25470276 |
41 | ZAP70 | 1.25311132 |
42 | PRKCH | 1.24452483 |
43 | MST1R | 1.20663464 |
44 | MAP4K2 | 1.19261036 |
45 | NTRK1 | 1.19029217 |
46 | CHUK | 1.18693808 |
47 | JAK1 | 1.18543954 |
48 | ERBB4 | 1.13330923 |
49 | SYK | 1.11374905 |
50 | GRK1 | 1.09099944 |
51 | CAMK1D | 1.08645056 |
52 | CAMK1G | 1.05735849 |
53 | NUAK1 | 1.04919386 |
54 | PTK2 | 1.04793143 |
55 | MAPK7 | 1.04725648 |
56 | EIF2AK2 | 1.04162623 |
57 | JAK2 | 1.03815769 |
58 | CAMKK1 | 1.03489015 |
59 | JAK3 | 1.02620034 |
60 | MAP3K7 | 1.02459555 |
61 | NEK9 | 1.00703777 |
62 | CSF1R | 0.98965463 |
63 | MAP3K10 | 0.98350467 |
64 | BMPR2 | 0.97175566 |
65 | LCK | 0.94891236 |
66 | LMTK2 | 0.93116753 |
67 | TGFBR2 | 0.92586391 |
68 | FGFR3 | 0.92125018 |
69 | BMX | 0.91927858 |
70 | SGK3 | 0.91281042 |
71 | PAK3 | 0.90632206 |
72 | PIM1 | 0.90343093 |
73 | FER | 0.89177409 |
74 | ITK | 0.87584372 |
75 | LRRK2 | 0.87358448 |
76 | PDPK1 | 0.84746232 |
77 | PHKG2 | 0.82789251 |
78 | PHKG1 | 0.82789251 |
79 | MAPKAPK3 | 0.82782540 |
80 | RPS6KA2 | 0.81610525 |
81 | TYRO3 | 0.80310753 |
82 | FLT3 | 0.79555876 |
83 | ACVR1B | 0.79164085 |
84 | OBSCN | 0.78767133 |
85 | PDK3 | 0.77732189 |
86 | PDK4 | 0.77732189 |
87 | PAK6 | 0.77458685 |
88 | WNK4 | 0.77211938 |
89 | MET | 0.76336037 |
90 | TYK2 | 0.76150122 |
91 | DMPK | 0.75302086 |
92 | MAP3K1 | 0.74633611 |
93 | PIK3CA | 0.73406670 |
94 | HCK | 0.73175385 |
95 | MAPK11 | 0.72959434 |
96 | PRKAA2 | 0.72405365 |
97 | CDK8 | 0.71637938 |
98 | DDR2 | 0.71191236 |
99 | LYN | 0.71107428 |
100 | PRKD1 | 0.69962316 |
101 | PDK1 | 0.69713446 |
102 | IGF1R | 0.69705284 |
103 | SGK223 | 0.68148029 |
104 | SGK494 | 0.68148029 |
105 | TBK1 | 0.68023902 |
106 | PIK3CG | 0.67781571 |
107 | ERBB2 | 0.67381714 |
108 | MAP2K1 | 0.65711974 |
109 | MAP3K9 | 0.65595203 |
110 | GSK3A | 0.65211648 |
111 | BTK | 0.65060413 |
112 | CSK | 0.64873168 |
113 | EEF2K | 0.63351280 |
114 | PDGFRB | 0.63248974 |
115 | SCYL2 | 0.63166130 |
116 | TAOK1 | 0.62992661 |
117 | STK38 | 0.62133120 |
118 | PTK2B | 0.60867484 |
119 | MOS | 0.60602558 |
120 | PINK1 | 0.60028622 |
121 | TRPM7 | 0.58023996 |
122 | EPHA4 | 0.57817473 |
123 | PRKAA1 | 0.56161019 |
124 | DYRK1B | 0.55780949 |
125 | ROCK1 | 0.54759488 |
126 | PRKCZ | 0.54166883 |
127 | GRK6 | 0.53358326 |
128 | MAP3K4 | 0.53090640 |
129 | MAP3K3 | 0.53011056 |
130 | RIPK4 | 0.52477807 |
131 | MAP3K13 | 0.52091758 |
132 | ARAF | 0.51606807 |
133 | SGK2 | 0.51288960 |
134 | MAP2K3 | 0.51217103 |
135 | LIMK1 | 0.51009685 |
136 | STK11 | 0.50634579 |
137 | IRAK1 | 0.50459388 |
138 | RPS6KA6 | 0.50152485 |
139 | MAPKAPK2 | 0.49970998 |
140 | PRKACG | 0.49927729 |
141 | MAPK12 | 0.49431434 |
142 | ICK | 0.49028719 |
143 | MARK3 | 0.47437441 |
144 | MTOR | 0.47110235 |
145 | GRK5 | 0.46730403 |
146 | CDK6 | 0.42788443 |
147 | WNK1 | 0.41933429 |
148 | RPS6KL1 | 0.41108416 |
149 | RPS6KC1 | 0.41108416 |
150 | EGFR | 0.40904640 |
151 | MAPK4 | 0.40111702 |
152 | ABL2 | 0.40025006 |
153 | PRKCQ | 0.39483845 |
154 | MAP2K6 | 0.35443464 |
155 | MAPK3 | 0.35310327 |
156 | ABL1 | 0.34685187 |
157 | INSR | 0.32703670 |
158 | TNK2 | 0.32298061 |
159 | STK10 | 0.31678915 |
160 | RAF1 | 0.30242971 |
161 | RPS6KA1 | 0.30201195 |
162 | IRAK4 | 0.29248409 |
163 | CAMKK2 | 0.28844597 |
164 | ADRBK1 | 0.28089533 |
165 | TEC | 0.26534958 |
166 | NEK6 | 0.26016837 |
167 | MST4 | 0.24900254 |
168 | RPS6KA5 | 0.24545439 |
169 | TIE1 | 0.24362929 |
170 | PRKCD | 0.23605537 |
171 | FYN | 0.23189966 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.22571988 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.84262911 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70128239 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17454944 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89451977 |
6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.85302020 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.80299324 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.75910727 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.69065441 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51977702 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49874768 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47901296 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36900012 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.29679119 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22749094 |
16 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.22290480 |
17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18861546 |
18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.17084675 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.16087694 |
20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.04608377 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04085848 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02598164 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98191431 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97873971 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94115005 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.91005341 |
27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88973729 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.86580289 |
29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86408269 |
30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79807518 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.74014245 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71789170 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65059637 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.63399458 |
35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58948586 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57847332 |
37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57389759 |
38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56359792 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56279341 |
40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56239333 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55054476 |
42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54317566 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48900060 |
44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47162447 |
45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.41901198 |
46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40666458 |
47 | Allograft rejection_Homo sapiens_hsa05330 | 1.38249364 |
48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.35183183 |
49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34901954 |
50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32988340 |
51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32589640 |
52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31124606 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29708226 |
54 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29318136 |
55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28327887 |
56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.27540777 |
57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24952594 |
58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24520966 |
59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23980151 |
60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19038171 |
61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13691966 |
62 | ABC transporters_Homo sapiens_hsa02010 | 1.11883258 |
63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11377247 |
64 | Measles_Homo sapiens_hsa05162 | 1.09593655 |
65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07925590 |
66 | Phototransduction_Homo sapiens_hsa04744 | 1.07751425 |
67 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06516399 |
68 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04479750 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03508465 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01482461 |
71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99563744 |
72 | Malaria_Homo sapiens_hsa05144 | 0.96706119 |
73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95437510 |
74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94715000 |
75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92780315 |
76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92449887 |
77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92322106 |
78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92259751 |
79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91723585 |
80 | Morphine addiction_Homo sapiens_hsa05032 | 0.87028338 |
81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86338426 |
82 | Lysine degradation_Homo sapiens_hsa00310 | 0.85765015 |
83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82978869 |
84 | Apoptosis_Homo sapiens_hsa04210 | 0.82081636 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80492796 |
86 | Insulin resistance_Homo sapiens_hsa04931 | 0.77515970 |
87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77208815 |
88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76751506 |
89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74805803 |
90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71886950 |
91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69406203 |
92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68852089 |
93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67405815 |
94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66666501 |
95 | Shigellosis_Homo sapiens_hsa05131 | 0.65904765 |
96 | Asthma_Homo sapiens_hsa05310 | 0.65572346 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.65135236 |
98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65134051 |
99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62556971 |
100 | Renin secretion_Homo sapiens_hsa04924 | 0.62020815 |
101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59851714 |
102 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58095267 |
103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57605839 |
104 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56141450 |
105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55815309 |
106 | Pertussis_Homo sapiens_hsa05133 | 0.54782779 |
107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53136963 |
108 | Hepatitis C_Homo sapiens_hsa05160 | 0.52747379 |
109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51051904 |
110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49908783 |
111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48968501 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48947250 |
113 | Salivary secretion_Homo sapiens_hsa04970 | 0.48682849 |
114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48506453 |
115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45502566 |
116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45049428 |
117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44139178 |
118 | Taste transduction_Homo sapiens_hsa04742 | 0.43759598 |
119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42028742 |
120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40318379 |
121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40227357 |
122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39723590 |
123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37999778 |
124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37860392 |
125 | Legionellosis_Homo sapiens_hsa05134 | 0.37156184 |
126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36940692 |
127 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36620697 |
128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36013813 |
129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33602977 |
130 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33400996 |
131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33101630 |
132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32707829 |
133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32379890 |
134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32367792 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31868813 |
136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31422810 |
137 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31362986 |
138 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31348444 |
139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31331252 |
140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31143435 |
141 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30770909 |
142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29123005 |
143 | Amoebiasis_Homo sapiens_hsa05146 | 0.26682165 |
144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.26464192 |
145 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.25562267 |
146 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23965601 |
147 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23941401 |
148 | Endocytosis_Homo sapiens_hsa04144 | 0.23461863 |
149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23137790 |
150 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22579564 |
151 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22447726 |
152 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21095253 |
153 | Lysosome_Homo sapiens_hsa04142 | 0.20602582 |
154 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19439449 |
155 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17922226 |
156 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.17500352 |
157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17273402 |
158 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16057526 |
159 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14534410 |
160 | Focal adhesion_Homo sapiens_hsa04510 | 0.14079310 |
161 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13899044 |
162 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13414860 |
163 | Insulin secretion_Homo sapiens_hsa04911 | 0.10266118 |
164 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.10141535 |
165 | Metabolic pathways_Homo sapiens_hsa01100 | 0.09885648 |
166 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.09389707 |
167 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.08197719 |
168 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07829818 |
169 | Bladder cancer_Homo sapiens_hsa05219 | 0.07646020 |